Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Total 13F shares
-
27,956,363
-
Share change
-
-592,693
-
Total reported value
-
$998,030,405
-
Price per share
-
$36.15
-
Number of holders
-
59
-
Value change
-
-$18,654,367
-
Number of buys
-
42
-
Number of sells
-
26
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q4 2020
As of 31 Dec 2020 Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,956,363 shares of stock of the company.
Largest 10 holders included FMR LLC, Vivo Capital, LLC, Novo Holdings A/S, venBio Partners LLC, Newlight Partners LP, JANUS HENDERSON GROUP PLC, Aisling Capital Management LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, PERCEPTIVE ADVISORS LLC, and BlackRock Inc..
This table shows 59 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.